Anti-TM3 antibodies and pharmaceutical compositions comprising such antibodies, and methods of using and using such as the treatment of cancer or infectious diseases or T-cell dysfunction disorders are disclosed. Bispecific antibodies to TIM-3 and other targets are also disclosed as preferred embodiments of bispecific antibodies to TIM-3 and CD3.
展开▼